SiteOne Therapeutics, Inc., a clinical-stage biopharmaceutical company developing non-opioid treatments to address pain, cough and other conditions involving hypersensitivity of the nervous system, announced...
Pathogenomix Inc., a Next Generation Sequencing, pathogen diagnostic company, announced that the US Food and Drug Administration (FDA) has granted it a Breakthrough Device...
Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced receipt of FDA approval...
With three billion people actively playing games today and fueled by a new generation steeped in the joys of interactive entertainment, gaming is now...
